Using genetics alone (PNPLA3, SOD2, KLF6, and LPIN1), one group was able to predict the presence of NASH in a cohort of children with NAFLD, though it was not useful in the prediction of fibrosis[128]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatohepatitis.